These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 12917432)
41. Characterization of the nucleation process of lysozyme at physiological pH: primary but not sole process. Navarra G; Troia F; Militello V; Leone M Biophys Chem; 2013; 177-178():24-33. PubMed ID: 23618623 [TBL] [Abstract][Full Text] [Related]
42. Molecular model of an alpha-helical prion protein dimer and its monomeric subunits as derived from chemical cross-linking and molecular modeling calculations. Kaimann T; Metzger S; Kuhlmann K; Brandt B; Birkmann E; Höltje HD; Riesner D J Mol Biol; 2008 Feb; 376(2):582-96. PubMed ID: 18158160 [TBL] [Abstract][Full Text] [Related]
43. Folding of prion protein to its native alpha-helical conformation is under kinetic control. Baskakov IV; Legname G; Prusiner SB; Cohen FE J Biol Chem; 2001 Jun; 276(23):19687-90. PubMed ID: 11306559 [TBL] [Abstract][Full Text] [Related]
44. Steric zipper formed by hydrophobic peptide fragment of Syrian hamster prion protein. Cheng HM; Tsai TW; Huang WY; Lee HK; Lian HY; Chou FC; Mou Y; Chan JC Biochemistry; 2011 Aug; 50(32):6815-23. PubMed ID: 21749158 [TBL] [Abstract][Full Text] [Related]
45. Reversible amyloid formation by the p53 tetramerization domain and a cancer-associated mutant. Lee AS; Galea C; DiGiammarino EL; Jun B; Murti G; Ribeiro RC; Zambetti G; Schultz CP; Kriwacki RW J Mol Biol; 2003 Mar; 327(3):699-709. PubMed ID: 12634062 [TBL] [Abstract][Full Text] [Related]
46. The role of the 132-160 region in prion protein conformational transitions. Torrent J; Alvarez-Martinez MT; Liautard JP; Balny C; Lange R Protein Sci; 2005 Apr; 14(4):956-67. PubMed ID: 15772306 [TBL] [Abstract][Full Text] [Related]
47. Solid-state NMR studies of the prion protein H1 fragment. Heller J; Kolbert AC; Larsen R; Ernst M; Bekker T; Baldwin M; Prusiner SB; Pines A; Wemmer DE Protein Sci; 1996 Aug; 5(8):1655-61. PubMed ID: 8844854 [TBL] [Abstract][Full Text] [Related]
48. Residue-specific mobility changes in soluble oligomers of the prion protein define regions involved in aggregation. Glaves JP; Ladner-Keay CL; Bjorndahl TC; Wishart DS; Sykes BD Biochim Biophys Acta Proteins Proteom; 2018 Sep; 1866(9):982-988. PubMed ID: 29935976 [TBL] [Abstract][Full Text] [Related]
49. Structural intermediates in the putative pathway from the cellular prion protein to the pathogenic form. Jansen K; Schäfer O; Birkmann E; Post K; Serban H; Prusiner SB; Riesner D Biol Chem; 2001 Apr; 382(4):683-91. PubMed ID: 11405232 [TBL] [Abstract][Full Text] [Related]
50. Membrane interactions and conformational preferences of human and avian prion N-terminal tandem repeats: the role of copper(II) ions, pH, and membrane mimicking environments. Di Natale G; Pappalardo G; Milardi D; Sciacca MF; Attanasio F; La Mendola D; Rizzarelli E J Phys Chem B; 2010 Nov; 114(43):13830-8. PubMed ID: 20936829 [TBL] [Abstract][Full Text] [Related]
51. Insights into Kinetics of Agitation-Induced Aggregation of Hen Lysozyme under Heat and Acidic Conditions from Various Spectroscopic Methods. Chaari A; Fahy C; Chevillot-Biraud A; Rholam M PLoS One; 2015; 10(11):e0142095. PubMed ID: 26571264 [TBL] [Abstract][Full Text] [Related]
52. Perturbation of the secondary structure of the scrapie prion protein under conditions that alter infectivity. Gasset M; Baldwin MA; Fletterick RJ; Prusiner SB Proc Natl Acad Sci U S A; 1993 Jan; 90(1):1-5. PubMed ID: 8419912 [TBL] [Abstract][Full Text] [Related]
53. Molecular properties of complexes formed between the prion protein and synthetic peptides. Kaneko K; Wille H; Mehlhorn I; Zhang H; Ball H; Cohen FE; Baldwin MA; Prusiner SB J Mol Biol; 1997 Jul; 270(4):574-86. PubMed ID: 9245588 [TBL] [Abstract][Full Text] [Related]
54. Nucleation-dependent conformational conversion of the Y145Stop variant of human prion protein: structural clues for prion propagation. Kundu B; Maiti NR; Jones EM; Surewicz KA; Vanik DL; Surewicz WK Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12069-74. PubMed ID: 14519851 [TBL] [Abstract][Full Text] [Related]
55. Solution structure of Syrian hamster prion protein rPrP(90-231). Liu H; Farr-Jones S; Ulyanov NB; Llinas M; Marqusee S; Groth D; Cohen FE; Prusiner SB; James TL Biochemistry; 1999 Apr; 38(17):5362-77. PubMed ID: 10220323 [TBL] [Abstract][Full Text] [Related]
56. Study of the conformational transition of A beta(1-42) using D-amino acid replacement analogues. Janek K; Rothemund S; Gast K; Beyermann M; Zipper J; Fabian H; Bienert M; Krause E Biochemistry; 2001 May; 40(18):5457-63. PubMed ID: 11331010 [TBL] [Abstract][Full Text] [Related]
57. Polymorphism at residue 129 modulates the conformational conversion of the D178N variant of human prion protein 90-231. Apetri AC; Vanik DL; Surewicz WK Biochemistry; 2005 Dec; 44(48):15880-8. PubMed ID: 16313190 [TBL] [Abstract][Full Text] [Related]
58. Thermal stability and conformational transitions of scrapie amyloid (prion) protein correlate with infectivity. Safar J; Roller PP; Gajdusek DC; Gibbs CJ Protein Sci; 1993 Dec; 2(12):2206-16. PubMed ID: 7905316 [TBL] [Abstract][Full Text] [Related]
59. Nucleic acid induced unfolding of recombinant prion protein globular fragment is pH dependent. Bera A; Nandi PK Protein Sci; 2014 Dec; 23(12):1780-8. PubMed ID: 25271002 [TBL] [Abstract][Full Text] [Related]
60. Steric zipper of the amyloid fibrils formed by residues 109-122 of the Syrian hamster prion protein. Lee SW; Mou Y; Lin SY; Chou FC; Tseng WH; Chen CH; Lu CY; Yu SS; Chan JC J Mol Biol; 2008 May; 378(5):1142-54. PubMed ID: 18423487 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]